# Cangrelor Prasugrel Transition Study

> **NCT01852019** · PHASE2 · COMPLETED · sponsor: **The Medicines Company** · enrollment: 12 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Cangrelor
- **DRUG:** Prasugrel

## Key facts

- **NCT ID:** NCT01852019
- **Lead sponsor:** The Medicines Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01852019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01852019, "Cangrelor Prasugrel Transition Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01852019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*